Junko Okabe‐Kado - Concepedia

Author

Junko Okabe‐Kado

Saitama Cancer Center

Also Known As

J OKABEKADO, J Okabe-Kado, J. Okabe-Kado, JUNKO OKABE-KADO, Junko Okabe-Kado, Junko Okabe‐Kado

100

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

Saitama Cancer Center Shimane University Toho University The University of Osaka Osaka Research Institute of Industrial Science and Technology

About

Junko Okabe‐Kado is an author at Saitama Cancer Center specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	40	1.1K
2	Cell Biology	19	36	989
3	Health Sciences	6	6	105
4	Natural Sciences	6	6	217
5	Biochemistry	3	3	57

Junko Okabe‐Kado

Publications

Citations

H-Index

Page 1

	Year	Citations
Induction of erythroid differentiation of K562 human leukemic cells by herbimycin A, an inhibitor of tyrosine kinase activity. Y Honma, Junko Okabe‐Kado, Motoo Hozumi, PubMed Hematological MalignancySignal TransductionTyrosine Protein KinaseMedicineMixed-phenotype Acute Leukemia	1989	117
Identity of a differentiation inhibiting factor for mouse myeloid leukemia cells with NM23/nucleoside diphosphate kinase Junko Okabe‐Kado, Takashi Kasukabe, Yoshio Honma, Biochemical and Biophysical Research Communications Hematological MalignancyChromatinNm23/nucleoside Diphosphate KinaseCell RegulationNatural Sciences	1992	110
Combined treatment with cotylenin A and phenethyl isothiocyanate induces strong antitumor activity mainly through the induction of ferroptotic cell death in human pancreatic cancer cells Takashi Kasukabe, Yoshio Honma, Junko Okabe‐Kado, Oncology Reports	2016	90
Serum nm23-H1 protein as a prognostic factor in aggressive non-Hodgkin lymphoma Nozomi Niitsu, Junko Okabe‐Kado, Masataka Okamoto, Blood	2001	74
Expression of Ah receptor (TCDD receptor) during human monocytic differentiation Shin-ichi Hayashio, Junko Okabe‐Kado, Yoshio Honma, Carcinogenesis	1995	72
A new function of Nm23/NDP kinase as a differentiation inhibitory factor, which does not require it's kinase activity Junko Okabe‐Kado, Takashi Kasukabe, Motoo Hozumi, FEBS Letters	1995	67
Effects of combined treatment with rapamycin and cotylenin A, a novel differentiation-inducing agent, on human breast carcinoma MCF-7 cells and xenografts Takashi Kasukabe, Junko Okabe‐Kado, Nobuo Kato, Breast Cancer Research	2005	61
Inhibition of <i>abl</i> Oncogene Tyrosine Kinase Induces Erythroid Differentiation of Human Myelogenous Leukemia K562 Cells Yoshio Honma, Junko Okabe‐Kado, Takashi Kasukabe, Japanese Journal of Cancer Research	1990	60
Ellagic acid, a natural polyphenolic compound, induces apoptosis and potentiates retinoic acid-induced differentiation of human leukemia HL-60 cells Yuki Hagiwara, Takashi Kasukabe, Yasuhiko Kaneko, International Journal of Hematology Hematological MalignancyMedicineApoptosisPharmacologyRetinoic Acid-induced Differentiation	2010	54
Differentiation inhibitory factor nm23 as a new prognostic factor in acute monocytic leukemia Akira Yokoyama, Junko Okabe‐Kado, Akihiko Sakashita, Blood	1996	53

Page 1